Loading…
Comparison of 99mTc-N-Pyridoxyl-5-Methyltryptophan and 99mTc-N-(3-Bromo-2,4,6-trimethylacetanilide)-Iminodiacetate as Hepatobiliary Radiopharmaceuticals in Rats
99mTc - N - (3-bromo-2,4,6-trimethylacetanilide)iminodiacetate (I) and 99mTc-N-pyridoxyl-5-methyl-tryptophan (II) have been described as having optimal properties as hepatobiliary radiopharmaceuticals. This study compared specificity for hepatobiliary excretion, blood disappearance, rates of biliary...
Saved in:
Published in: | Journal of pharmaceutical sciences 1984-12, Vol.73 (12), p.1861-1863 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c2349-aad59b97b813fa4c4e89536330980db73cf0e3ca501634d8af5de1e1ecaaaf9d3 |
container_end_page | 1863 |
container_issue | 12 |
container_start_page | 1861 |
container_title | Journal of pharmaceutical sciences |
container_volume | 73 |
creator | Fritzberg, Alan R. Bloedow, Duane C. Eshima, Dennis Johnson, Dennis L. |
description | 99mTc - N - (3-bromo-2,4,6-trimethylacetanilide)iminodiacetate (I) and 99mTc-N-pyridoxyl-5-methyl-tryptophan (II) have been described as having optimal properties as hepatobiliary radiopharmaceuticals. This study compared specificity for hepatobiliary excretion, blood disappearance, rates of biliary appearance, and pharmacokinetic parameters including hepatic clearance, volumes of distribution, and mean residence times in normal and sulfobromophthalein-treated rats. The specificity of I was higher as indicated by 94% in the bile at 90min compared to 91% for II in normal rats and a urine excretion of 0.3% for I compared with 1.9% for II. In sulfobromophthalein-treated animals, urine excretion increases were only to 0.5 and 3.0% for I and II, respectively. In control rats, blood disappearance was similar for both I and II, but II disappeared faster in treated animals. The clearance of II was 70 mL/min/kg in normal and 47 mL/min/kg in treated rats; clearance of I was 51 and 30 mL/min/kg in normal and treated rats, respectively. Volumes of distribution were larger for II. Compound I was superior in specificity while II was superior in clearance and excretion kinetics. |
doi_str_mv | 10.1002/jps.2600731259 |
format | article |
fullrecord | <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_jps_2600731259</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354915464925</els_id><sourcerecordid>JPS2600731259</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2349-aad59b97b813fa4c4e89536330980db73cf0e3ca501634d8af5de1e1ecaaaf9d3</originalsourceid><addsrcrecordid>eNqFkEFP3DAQha2qlbqlXHvOgQOV8NaO4yQ-0lVhqSisFiqO1qztCEMSR7bbkn_DT8VLqkU9VMgHy-Pvzbx5CH2iZE4Jyb_cDWGel4RUjOZcvEEzynOCS0Krt2iWgBwzXoj36EMId4SQknA-Q48L1w3gbXB95ppMiO5a4Qu8Gr3V7mFsMcc_TLwd2-jHIbrhFvoMer0DDxn-6l3ncH5UHJU4ets946BMhN62VpvP-KyzvdP2uRZNBiFbmgGi26R_8GO2Bm23rX2XkF_RKmhDZvtUj-Ejetekp9n_e--hnyffrhdLfH55erY4PscqZ4XAAJqLjag2NWUNFKowteCsZIyImuhNxVRDDFPACS1ZoWtouDY0HQUAjdBsD82nvsq7ELxp5JB2Se4kJXKbr0z5ypd8k-BgEgwQkuHGQ69s2KnqmnFWV69ivChytsXEhP2xrRlfmS2_r67-cYInrQ3RPOy04O9lWbGKy5uLU3m1Xp4sVpzJdeLriTcpz9_WeBmUNb0y2nqjotTO_m_pJ_ZQvL0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Comparison of 99mTc-N-Pyridoxyl-5-Methyltryptophan and 99mTc-N-(3-Bromo-2,4,6-trimethylacetanilide)-Iminodiacetate as Hepatobiliary Radiopharmaceuticals in Rats</title><source>Wiley Online Library Journals</source><creator>Fritzberg, Alan R. ; Bloedow, Duane C. ; Eshima, Dennis ; Johnson, Dennis L.</creator><creatorcontrib>Fritzberg, Alan R. ; Bloedow, Duane C. ; Eshima, Dennis ; Johnson, Dennis L.</creatorcontrib><description>99mTc - N - (3-bromo-2,4,6-trimethylacetanilide)iminodiacetate (I) and 99mTc-N-pyridoxyl-5-methyl-tryptophan (II) have been described as having optimal properties as hepatobiliary radiopharmaceuticals. This study compared specificity for hepatobiliary excretion, blood disappearance, rates of biliary appearance, and pharmacokinetic parameters including hepatic clearance, volumes of distribution, and mean residence times in normal and sulfobromophthalein-treated rats. The specificity of I was higher as indicated by 94% in the bile at 90min compared to 91% for II in normal rats and a urine excretion of 0.3% for I compared with 1.9% for II. In sulfobromophthalein-treated animals, urine excretion increases were only to 0.5 and 3.0% for I and II, respectively. In control rats, blood disappearance was similar for both I and II, but II disappeared faster in treated animals. The clearance of II was 70 mL/min/kg in normal and 47 mL/min/kg in treated rats; clearance of I was 51 and 30 mL/min/kg in normal and treated rats, respectively. Volumes of distribution were larger for II. Compound I was superior in specificity while II was superior in clearance and excretion kinetics.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.2600731259</identifier><identifier>CODEN: JPMSAE</identifier><language>eng</language><publisher>Washington: Elsevier Inc</publisher><subject>Applied sciences ; Biological and medical sciences ; Contrast media. Radiopharmaceuticals ; Exact sciences and technology ; Hepatobiliary radiopharmaceuticals-99mTc-labeled compounds compared ; Hepatobiliary radiopharmaceuticals—99mTc-labeled compounds compared, sulfobromophthalein-treated and normal rats ; Medical sciences ; Other techniques and industries ; Pharmacology. Drug treatments ; Radiopharmaceuticals-99mTc-labeled hepatobiliary compounds compared ; Radiopharmaceuticals—99mTc-labeled hepatobiliary compounds compared, sulfobromophthalein-treated and normal rats ; rats ; Sulfobromophthalein-effect on hepatobiliary radiopharmaceuticals ; sulfobromophthalein-treated and normal rats ; Sulfobromophthalein—effect on hepatobiliary radiopharmaceuticals, rats</subject><ispartof>Journal of pharmaceutical sciences, 1984-12, Vol.73 (12), p.1861-1863</ispartof><rights>1984 Wiley‐Liss, Inc., A Wiley Company</rights><rights>Copyright © 1984 Wiley‐Liss, Inc., A Wiley Company</rights><rights>1986 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2349-aad59b97b813fa4c4e89536330980db73cf0e3ca501634d8af5de1e1ecaaaf9d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.2600731259$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjps.2600731259$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=8544237$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=8835387$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Fritzberg, Alan R.</creatorcontrib><creatorcontrib>Bloedow, Duane C.</creatorcontrib><creatorcontrib>Eshima, Dennis</creatorcontrib><creatorcontrib>Johnson, Dennis L.</creatorcontrib><title>Comparison of 99mTc-N-Pyridoxyl-5-Methyltryptophan and 99mTc-N-(3-Bromo-2,4,6-trimethylacetanilide)-Iminodiacetate as Hepatobiliary Radiopharmaceuticals in Rats</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>99mTc - N - (3-bromo-2,4,6-trimethylacetanilide)iminodiacetate (I) and 99mTc-N-pyridoxyl-5-methyl-tryptophan (II) have been described as having optimal properties as hepatobiliary radiopharmaceuticals. This study compared specificity for hepatobiliary excretion, blood disappearance, rates of biliary appearance, and pharmacokinetic parameters including hepatic clearance, volumes of distribution, and mean residence times in normal and sulfobromophthalein-treated rats. The specificity of I was higher as indicated by 94% in the bile at 90min compared to 91% for II in normal rats and a urine excretion of 0.3% for I compared with 1.9% for II. In sulfobromophthalein-treated animals, urine excretion increases were only to 0.5 and 3.0% for I and II, respectively. In control rats, blood disappearance was similar for both I and II, but II disappeared faster in treated animals. The clearance of II was 70 mL/min/kg in normal and 47 mL/min/kg in treated rats; clearance of I was 51 and 30 mL/min/kg in normal and treated rats, respectively. Volumes of distribution were larger for II. Compound I was superior in specificity while II was superior in clearance and excretion kinetics.</description><subject>Applied sciences</subject><subject>Biological and medical sciences</subject><subject>Contrast media. Radiopharmaceuticals</subject><subject>Exact sciences and technology</subject><subject>Hepatobiliary radiopharmaceuticals-99mTc-labeled compounds compared</subject><subject>Hepatobiliary radiopharmaceuticals—99mTc-labeled compounds compared, sulfobromophthalein-treated and normal rats</subject><subject>Medical sciences</subject><subject>Other techniques and industries</subject><subject>Pharmacology. Drug treatments</subject><subject>Radiopharmaceuticals-99mTc-labeled hepatobiliary compounds compared</subject><subject>Radiopharmaceuticals—99mTc-labeled hepatobiliary compounds compared, sulfobromophthalein-treated and normal rats</subject><subject>rats</subject><subject>Sulfobromophthalein-effect on hepatobiliary radiopharmaceuticals</subject><subject>sulfobromophthalein-treated and normal rats</subject><subject>Sulfobromophthalein—effect on hepatobiliary radiopharmaceuticals, rats</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><recordid>eNqFkEFP3DAQha2qlbqlXHvOgQOV8NaO4yQ-0lVhqSisFiqO1qztCEMSR7bbkn_DT8VLqkU9VMgHy-Pvzbx5CH2iZE4Jyb_cDWGel4RUjOZcvEEzynOCS0Krt2iWgBwzXoj36EMId4SQknA-Q48L1w3gbXB95ppMiO5a4Qu8Gr3V7mFsMcc_TLwd2-jHIbrhFvoMer0DDxn-6l3ncH5UHJU4ets946BMhN62VpvP-KyzvdP2uRZNBiFbmgGi26R_8GO2Bm23rX2XkF_RKmhDZvtUj-Ejetekp9n_e--hnyffrhdLfH55erY4PscqZ4XAAJqLjag2NWUNFKowteCsZIyImuhNxVRDDFPACS1ZoWtouDY0HQUAjdBsD82nvsq7ELxp5JB2Se4kJXKbr0z5ypd8k-BgEgwQkuHGQ69s2KnqmnFWV69ivChytsXEhP2xrRlfmS2_r67-cYInrQ3RPOy04O9lWbGKy5uLU3m1Xp4sVpzJdeLriTcpz9_WeBmUNb0y2nqjotTO_m_pJ_ZQvL0</recordid><startdate>198412</startdate><enddate>198412</enddate><creator>Fritzberg, Alan R.</creator><creator>Bloedow, Duane C.</creator><creator>Eshima, Dennis</creator><creator>Johnson, Dennis L.</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>American Pharmaceutical Association</general><scope>BSCLL</scope><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>198412</creationdate><title>Comparison of 99mTc-N-Pyridoxyl-5-Methyltryptophan and 99mTc-N-(3-Bromo-2,4,6-trimethylacetanilide)-Iminodiacetate as Hepatobiliary Radiopharmaceuticals in Rats</title><author>Fritzberg, Alan R. ; Bloedow, Duane C. ; Eshima, Dennis ; Johnson, Dennis L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2349-aad59b97b813fa4c4e89536330980db73cf0e3ca501634d8af5de1e1ecaaaf9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Applied sciences</topic><topic>Biological and medical sciences</topic><topic>Contrast media. Radiopharmaceuticals</topic><topic>Exact sciences and technology</topic><topic>Hepatobiliary radiopharmaceuticals-99mTc-labeled compounds compared</topic><topic>Hepatobiliary radiopharmaceuticals—99mTc-labeled compounds compared, sulfobromophthalein-treated and normal rats</topic><topic>Medical sciences</topic><topic>Other techniques and industries</topic><topic>Pharmacology. Drug treatments</topic><topic>Radiopharmaceuticals-99mTc-labeled hepatobiliary compounds compared</topic><topic>Radiopharmaceuticals—99mTc-labeled hepatobiliary compounds compared, sulfobromophthalein-treated and normal rats</topic><topic>rats</topic><topic>Sulfobromophthalein-effect on hepatobiliary radiopharmaceuticals</topic><topic>sulfobromophthalein-treated and normal rats</topic><topic>Sulfobromophthalein—effect on hepatobiliary radiopharmaceuticals, rats</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fritzberg, Alan R.</creatorcontrib><creatorcontrib>Bloedow, Duane C.</creatorcontrib><creatorcontrib>Eshima, Dennis</creatorcontrib><creatorcontrib>Johnson, Dennis L.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>CrossRef</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fritzberg, Alan R.</au><au>Bloedow, Duane C.</au><au>Eshima, Dennis</au><au>Johnson, Dennis L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of 99mTc-N-Pyridoxyl-5-Methyltryptophan and 99mTc-N-(3-Bromo-2,4,6-trimethylacetanilide)-Iminodiacetate as Hepatobiliary Radiopharmaceuticals in Rats</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>1984-12</date><risdate>1984</risdate><volume>73</volume><issue>12</issue><spage>1861</spage><epage>1863</epage><pages>1861-1863</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><coden>JPMSAE</coden><abstract>99mTc - N - (3-bromo-2,4,6-trimethylacetanilide)iminodiacetate (I) and 99mTc-N-pyridoxyl-5-methyl-tryptophan (II) have been described as having optimal properties as hepatobiliary radiopharmaceuticals. This study compared specificity for hepatobiliary excretion, blood disappearance, rates of biliary appearance, and pharmacokinetic parameters including hepatic clearance, volumes of distribution, and mean residence times in normal and sulfobromophthalein-treated rats. The specificity of I was higher as indicated by 94% in the bile at 90min compared to 91% for II in normal rats and a urine excretion of 0.3% for I compared with 1.9% for II. In sulfobromophthalein-treated animals, urine excretion increases were only to 0.5 and 3.0% for I and II, respectively. In control rats, blood disappearance was similar for both I and II, but II disappeared faster in treated animals. The clearance of II was 70 mL/min/kg in normal and 47 mL/min/kg in treated rats; clearance of I was 51 and 30 mL/min/kg in normal and treated rats, respectively. Volumes of distribution were larger for II. Compound I was superior in specificity while II was superior in clearance and excretion kinetics.</abstract><cop>Washington</cop><pub>Elsevier Inc</pub><doi>10.1002/jps.2600731259</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3549 |
ispartof | Journal of pharmaceutical sciences, 1984-12, Vol.73 (12), p.1861-1863 |
issn | 0022-3549 1520-6017 |
language | eng |
recordid | cdi_crossref_primary_10_1002_jps_2600731259 |
source | Wiley Online Library Journals |
subjects | Applied sciences Biological and medical sciences Contrast media. Radiopharmaceuticals Exact sciences and technology Hepatobiliary radiopharmaceuticals-99mTc-labeled compounds compared Hepatobiliary radiopharmaceuticals—99mTc-labeled compounds compared, sulfobromophthalein-treated and normal rats Medical sciences Other techniques and industries Pharmacology. Drug treatments Radiopharmaceuticals-99mTc-labeled hepatobiliary compounds compared Radiopharmaceuticals—99mTc-labeled hepatobiliary compounds compared, sulfobromophthalein-treated and normal rats rats Sulfobromophthalein-effect on hepatobiliary radiopharmaceuticals sulfobromophthalein-treated and normal rats Sulfobromophthalein—effect on hepatobiliary radiopharmaceuticals, rats |
title | Comparison of 99mTc-N-Pyridoxyl-5-Methyltryptophan and 99mTc-N-(3-Bromo-2,4,6-trimethylacetanilide)-Iminodiacetate as Hepatobiliary Radiopharmaceuticals in Rats |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T14%3A33%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%2099mTc-N-Pyridoxyl-5-Methyltryptophan%20and%2099mTc-N-(3-Bromo-2,4,6-trimethylacetanilide)-Iminodiacetate%20as%20Hepatobiliary%20Radiopharmaceuticals%20in%20Rats&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Fritzberg,%20Alan%20R.&rft.date=1984-12&rft.volume=73&rft.issue=12&rft.spage=1861&rft.epage=1863&rft.pages=1861-1863&rft.issn=0022-3549&rft.eissn=1520-6017&rft.coden=JPMSAE&rft_id=info:doi/10.1002/jps.2600731259&rft_dat=%3Cwiley_cross%3EJPS2600731259%3C/wiley_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2349-aad59b97b813fa4c4e89536330980db73cf0e3ca501634d8af5de1e1ecaaaf9d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |